BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1255745)

  • 21. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
    Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
    J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An immunohistologic study of reactive lymphocytes in breast tissue].
    Oyamada S; Oyama H; Tokunaga M
    Gan No Rinsho; 1988 Oct; 34(12):1685-9. PubMed ID: 2461454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease.
    Ramey WG; Hashim GA; Fitzpatrick HF
    Br J Surg; 1979 Dec; 66(12):848-52. PubMed ID: 315807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
    Metzgar RS; Mohanakumar T; Bolognesi DP
    J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic detection of breast cancer.
    Estes NC; Boehm OR; Jewell WR; Humphrey LJ
    Bull Soc Int Chir; 1974 Mar; 33(2):85-90. PubMed ID: 4210924
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte reactivity in patients with carcinoma of the breast and large bowel.
    Miller JJ; Gaffney PR; Rees JA; Symes MO
    Br J Cancer; 1975 Jul; 32(1):16-20. PubMed ID: 1236735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence rates and risk factors of benign breast neoplasms.
    Cole P; Mark Elwood J; Kaplan SD
    Am J Epidemiol; 1978 Aug; 108(2):112-20. PubMed ID: 707472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Search for the heterogenetic Forssman antigen in human breast tumor tissue].
    Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
    Biull Eksp Biol Med; 1981 Dec; 92(12):710-1. PubMed ID: 7326421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic (CEA)--like antigen in adenomas and cancers of the breast in human patients.
    Potomski J; Harlozińska A; Richter R; Starzyk H
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):461-8. PubMed ID: 92973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell- and antibody-mediated immune reactions of patients to cultured cells of breast carcinoma.
    Sinkovics JG; Reeves WJ; Cabiness JR
    J Natl Cancer Inst; 1972 Apr; 48(4):1145-9. PubMed ID: 5023675
    [No Abstract]   [Full Text] [Related]  

  • 34. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphocyte-mediated cytotoxicity on human tumor cells in vitro.
    Schwenke H; Schönfelder M
    Arch Geschwulstforsch; 1975; 45(8):802-9. PubMed ID: 1241765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of immunology in the diagnosis and treatment of cancer.
    Humphrey LJ; Pierce GE
    Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional hyperplastic lymph nodes in breast cancer: the role of lymphocytes and nodal macrophages. An immunological study with a five-year follow-up.
    Hickok DF; Miller L; Harris L
    Surgery; 1977 Nov; 82(5):710-5. PubMed ID: 199957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
    Oldham RK; Herberman RB
    J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
    [No Abstract]   [Full Text] [Related]  

  • 39. Active specific immunotherapy of human solid tumors.
    Rosato FE
    Ann N Y Acad Sci; 1976; 277(00):332-8. PubMed ID: 1069552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast.
    Gratterola R
    Cancer Res; 1978 Sep; 38(9):3051-4. PubMed ID: 679211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.